{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:50:24Z","timestamp":1750308624998,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":41,"publisher":"ACM","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,10]]},"DOI":"10.1145\/3592686.3592758","type":"proceedings-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T23:21:27Z","timestamp":1685575287000},"page":"297-304","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastric cancer's prognosis-related biomarker, RGS1, and its correlation with immune infiltration"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-9867","authenticated-orcid":false,"given":"Huiyun","family":"Pu","sequence":"first","affiliation":[{"name":"Hubei University of Chinese Medicine, China"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3335-8998","authenticated-orcid":false,"given":"Hongci","family":"Chen","sequence":"additional","affiliation":[{"name":"Hubei Hospital of Chinese Medicine, affiliated with Hubei University of Chinese Medicine, China"}]}],"member":"320","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"e_1_3_2_1_1_1","doi-asserted-by":"crossref","unstructured":"Thrift AP El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020 Mar;18(3):534-542.  Thrift AP El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020 Mar;18(3):534-542.","DOI":"10.1016\/j.cgh.2019.07.045"},{"key":"e_1_3_2_1_2_1","first-page":"127","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"2010","author":"Ferlay","unstructured":"Ferlay ,J; Bray , F.; Forman , D. ; Mathers , C. ; Parkin , N.M. ; Shin , H.-R . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 . Int. J. Cancer 2010 , 127 , 2893\u20132917. Ferlay,J; Bray , F.; Forman, D.; Mathers, C.; Parkin, N.M.; Shin, H.-R. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127, 2893\u20132917.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"crossref","unstructured":"Machlowska J Baj J Sitarz M Maciejewski R Sitarz R. Gastric Cancer: Epidemiology Risk Factors Classification Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020 Jun 4;21(11):4012.  Machlowska J Baj J Sitarz M Maciejewski R Sitarz R. Gastric Cancer: Epidemiology Risk Factors Classification Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020 Jun 4;21(11):4012.","DOI":"10.3390\/ijms21114012"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"crossref","unstructured":"Johnston FM Beckman M. Updates on Management of Gastric Cancer. Curr Oncol Rep. 2019 Jun 24;21(8):67.  Johnston FM Beckman M. Updates on Management of Gastric Cancer. Curr Oncol Rep. 2019 Jun 24;21(8):67.","DOI":"10.1007\/s11912-019-0820-4"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"crossref","unstructured":"Matsuoka T Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol. 2018 Jul 14;24(26):2818-2832.  Matsuoka T Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol. 2018 Jul 14;24(26):2818-2832.","DOI":"10.3748\/wjg.v24.i26.2818"},{"key":"e_1_3_2_1_6_1","volume-title":"R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther. 2007","author":"Bansal G","year":"2007","unstructured":"Bansal G , Druey KM , Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther. 2007 ; 116:473\u201395.Bansal G, Druey KM , Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther . 2007 ; 116:473\u201395. Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther. 2007; 116:473\u201395.Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther. 2007; 116:473\u201395."},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Bowman EP Campbell JJ Druey KM Scheschonka A Kehrl JH Butcher EC. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem. 1998 Oct 23;273(43):28040-8.  Bowman EP Campbell JJ Druey KM Scheschonka A Kehrl JH Butcher EC. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem. 1998 Oct 23;273(43):28040-8.","DOI":"10.1074\/jbc.273.43.28040"},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Squires KE Montanez-Miranda C Pandya RR Torres MP Hepler JR. Genetic analysis of rare human variants of regulators of G protein signaling proteins and their role in human physiology and disease. Pharm Rev. 2018; 70:446\u201374.  Squires KE Montanez-Miranda C Pandya RR Torres MP Hepler JR. Genetic analysis of rare human variants of regulators of G protein signaling proteins and their role in human physiology and disease. Pharm Rev. 2018; 70:446\u201374.","DOI":"10.1124\/pr.117.015354"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"crossref","unstructured":"Z. Wang M.A. Jensen J.C. Zenklusen A practical guide to the cancer genome atlas (TCGA) Methods Mol. Biol. (Clifton NJ). 1418 (2016) 111\u201314.  Z. Wang M.A. Jensen J.C. Zenklusen A practical guide to the cancer genome atlas (TCGA) Methods Mol. Biol. (Clifton NJ). 1418 (2016) 111\u201314.","DOI":"10.1007\/978-1-4939-3578-9_6"},{"key":"e_1_3_2_1_10_1","first-page":"15545","article-title":"Gene set enrichment analysis: aknowledge-based approach for interpreting genome-wide expression profiles","author":"Subramanian P.","year":"2005","unstructured":"Subramanian , P. Tamayo , V.K. Mootha , , Gene set enrichment analysis: aknowledge-based approach for interpreting genome-wide expression profiles , PNAS102 (43) ( 2005 ) 15545 \u2013 15550 . Subramanian, P. Tamayo, V.K. Mootha, , Gene set enrichment analysis: aknowledge-based approach for interpreting genome-wide expression profiles, PNAS102 (43) (2005) 15545\u201315550.","journal-title":"PNAS102 (43) ("},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"crossref","unstructured":"Yu G Wang LG Han Y He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16:284\u20137.  Yu G Wang LG Han Y He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16:284\u20137.","DOI":"10.1089\/omi.2011.0118"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"crossref","unstructured":"Reimand J Isserlin R Voisin V Kucera M Tannus-Lopes C Rostamianfar A Wadi L Meyer M Wong J Xu C Pathway enrichment analysis and visualization of omics data using:profiler GSEA cytoscape and Enrichment Map. Nat Protoc. 2019; 14:482\u2013517  Reimand J Isserlin R Voisin V Kucera M Tannus-Lopes C Rostamianfar A Wadi L Meyer M Wong J Xu C Pathway enrichment analysis and visualization of omics data using:profiler GSEA cytoscape and Enrichment Map. Nat Protoc. 2019; 14:482\u2013517","DOI":"10.1038\/s41596-018-0103-9"},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0307"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-4013-7"},{"key":"e_1_3_2_1_15_1","unstructured":"Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007 Feb 21; 7: 4.  Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007 Feb 21; 7: 4."},{"key":"e_1_3_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3804"},{"volume-title":"Roy A, Bottaro DP. Hepatocyte growth factor\/MET in cancer progression and biomarker discovery. Cancer Sci 2017","author":"Matsumoto K","key":"e_1_3_2_1_17_1","unstructured":"Matsumoto K , Umitsu M , De Silva DM , Roy A, Bottaro DP. Hepatocyte growth factor\/MET in cancer progression and biomarker discovery. Cancer Sci 2017 ; 108: 296-307. Matsumoto K, Umitsu M, De Silva DM, Roy A, Bottaro DP. Hepatocyte growth factor\/MET in cancer progression and biomarker discovery. Cancer Sci 2017; 108: 296-307."},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"crossref","unstructured":"Tang Z Li C Kang B Gao G Li C Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017 Jul 3;45(W1): W98-W102.  Tang Z Li C Kang B Gao G Li C Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017 Jul 3;45(W1): W98-W102.","DOI":"10.1093\/nar\/gkx247"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"crossref","unstructured":"Yl\u00e4-Herttuala S Rissanen TT V ajanto I Hartikainen J. V ascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 2007; 49: 1015-1026.  Yl\u00e4-Herttuala S Rissanen TT V ajanto I Hartikainen J. V ascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 2007; 49: 1015-1026.","DOI":"10.1016\/j.jacc.2006.09.053"},{"key":"e_1_3_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-015-9847-0"},{"key":"e_1_3_2_1_21_1","unstructured":"Tanabe S Aoyagi K Yokozaki H and Sasaki H. Regulated genes in mesenchymal stem cells  Tanabe S Aoyagi K Yokozaki H and Sasaki H. Regulated genes in mesenchymal stem cells"},{"volume-title":"World J Stem Cells 2015","key":"e_1_3_2_1_22_1","unstructured":"and gastric cancer. World J Stem Cells 2015 ; 7: 208-222. and gastric cancer. World J Stem Cells 2015; 7: 208-222."},{"volume-title":"Vivo 2017","author":"Katayama Y","key":"e_1_3_2_1_23_1","unstructured":"Katayama Y , Oshima T , Sakamaki K , Aoyama T , Sato T , Masudo K , Shiozawa M , Yoshikawa T , Rino Y , Imada T and Masuda M. Clinical significance of INHBA gene expression in patients with gastric cancer who receive curative resection followed by adjuvant S-1 chemotherapy . In Vivo 2017 ; 31: 565-571. Katayama Y, Oshima T, Sakamaki K, Aoyama T, Sato T, Masudo K, Shiozawa M, Yoshikawa T, Rino Y, Imada T and Masuda M. Clinical significance of INHBA gene expression in patients with gastric cancer who receive curative resection followed by adjuvant S-1 chemotherapy. In Vivo 2017; 31: 565-571."},{"key":"e_1_3_2_1_24_1","doi-asserted-by":"crossref","unstructured":"Wilhelm F Boger C Kruger S Behrens HM and Rocken C. Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer. Oncotarget 2017; 8: 50557-50569.  Wilhelm F Boger C Kruger S Behrens HM and Rocken C. Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer. Oncotarget 2017; 8: 50557-50569.","DOI":"10.18632\/oncotarget.10672"},{"key":"e_1_3_2_1_25_1","doi-asserted-by":"crossref","unstructured":"Zhang S Wang H Liu J Tao T Zeng Z Wang M. RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation. J Transl Med. 2022 Jul 25;20(1):334.  Zhang S Wang H Liu J Tao T Zeng Z Wang M. RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation. J Transl Med. 2022 Jul 25;20(1):334.","DOI":"10.1186\/s12967-022-03526-0"},{"key":"e_1_3_2_1_26_1","doi-asserted-by":"crossref","unstructured":"Bowman EP Campbell JJ Druey KM Scheschonka A Kehrl JH Butcher EC. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem. 1998 Oct 23;273(43):28040-8.  Bowman EP Campbell JJ Druey KM Scheschonka A Kehrl JH Butcher EC. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem. 1998 Oct 23;273(43):28040-8.","DOI":"10.1074\/jbc.273.43.28040"},{"key":"e_1_3_2_1_27_1","doi-asserted-by":"crossref","unstructured":"Hwang IY Park C Harrision KA Huang NN Kehrl JH. Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs. Genes Immun. 2010 Jul;11(5):384-96.  Hwang IY Park C Harrision KA Huang NN Kehrl JH. Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs. Genes Immun. 2010 Jul;11(5):384-96.","DOI":"10.1038\/gene.2010.27"},{"key":"e_1_3_2_1_28_1","unstructured":"Offermanns S Simon MI. Organization of Transmembrane Signalling by Heterotrimeric G Proteins. Cancer Surv (1996) 27: 177\u201398.  Offermanns S Simon MI. Organization of Transmembrane Signalling by Heterotrimeric G Proteins. Cancer Surv (1996) 27:177\u201398."},{"key":"e_1_3_2_1_29_1","doi-asserted-by":"crossref","unstructured":"Wierenga AT Vellenga E Schuringa JJ. Convergence of Hypoxia and Tgfb Pathways on Cell Cycle Regulation in Human Hematopoietic Stem\/Progenitor Cells. PloS One (2014) 9(3):  e93494.  Wierenga AT Vellenga E Schuringa JJ. Convergence of Hypoxia and Tgfb Pathways on Cell Cycle Regulation in Human Hematopoietic Stem\/Progenitor Cells. PloS One (2014) 9(3): e93494.","DOI":"10.1371\/journal.pone.0093494"},{"key":"e_1_3_2_1_30_1","first-page":"261","article-title":"(1990) Biochim","volume":"1049","author":"Murphy J.","unstructured":"Murphy , J. , and Norton , J. D . (1990) Biochim . Biophys. Acta 1049 , 261 \u2013 271 . \/ Hong, J. X., Wilson, G. L., Fox, C. H., and Kehrl, J. H. (1993) J. Immunol. 150,3895\u2013390. Murphy, J., and Norton, J. D. (1990) Biochim. Biophys. Acta 1049, 261\u2013271. \/ Hong, J. X., Wilson, G. L., Fox, C. H., and Kehrl, J. H. (1993) J. Immunol. 150,3895\u2013390.","journal-title":"Biophys. Acta"},{"key":"e_1_3_2_1_31_1","doi-asserted-by":"crossref","unstructured":"Blum JS Wearsch PA Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013; 31:443\u201373.  Blum JS Wearsch PA Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013; 31:443\u201373.","DOI":"10.1146\/annurev-immunol-032712-095910"},{"key":"e_1_3_2_1_32_1","doi-asserted-by":"crossref","unstructured":"Blank CU Haining WN Held W Hogan PG Kallies A Lugli E Defining T Cell Exhaustion. Nat Rev Immunol (2019) 19(11): 665\u201374.  Blank CU Haining WN Held W Hogan PG Kallies A Lugli E Defining T Cell Exhaustion. Nat Rev Immunol (2019) 19(11):665\u201374.","DOI":"10.1038\/s41577-019-0221-9"},{"key":"e_1_3_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28026"},{"key":"e_1_3_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02121.x"},{"key":"e_1_3_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1138"},{"key":"e_1_3_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198687"},{"key":"e_1_3_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23239"},{"key":"e_1_3_2_1_38_1","doi-asserted-by":"crossref","unstructured":"Vacca P Martini S Garelli V Passalacqua G Moretta L Mingari MC. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. Eur J Immunol. 2013 Feb;43(2):550-61.  Vacca P Martini S Garelli V Passalacqua G Moretta L Mingari MC. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. Eur J Immunol. 2013 Feb;43(2):550-61.","DOI":"10.1002\/eji.201242783"},{"key":"e_1_3_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2820"},{"key":"e_1_3_2_1_40_1","doi-asserted-by":"crossref","unstructured":"Cooper MA Fehniger TA Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633\u201340.  Cooper MA Fehniger TA Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633\u201340.","DOI":"10.1016\/S1471-4906(01)02060-9"},{"key":"e_1_3_2_1_41_1","doi-asserted-by":"crossref","unstructured":"Ferlazzo G Thomas D Lin SL Goodman K Morandi B Muller WA Moretta A Mu\u00a8nz C. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cellIg-like receptors and become cytolytic. J Immunol 2004; 172: 1455\u201362.  Ferlazzo G Thomas D Lin SL Goodman K Morandi B Muller WA Moretta A Mu\u00a8nz C. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cellIg-like receptors and become cytolytic. J Immunol 2004; 172: 1455\u201362.","DOI":"10.4049\/jimmunol.172.3.1455"}],"event":{"name":"BIC 2023: 2023 3rd International Conference on Bioinformatics and Intelligent Computing","acronym":"BIC 2023","location":"Sanya China"},"container-title":["Proceedings of the 2023 3rd International Conference on Bioinformatics and Intelligent Computing"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3592686.3592758","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3592686.3592758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:07:46Z","timestamp":1750273666000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3592686.3592758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":41,"alternative-id":["10.1145\/3592686.3592758","10.1145\/3592686"],"URL":"https:\/\/doi.org\/10.1145\/3592686.3592758","relation":{},"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"2023-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}